PLSE

Pulse Biosciences, Inc - Common Stock (PLSE)

About Pulse Biosciences, Inc - Common Stock (PLSE)

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.

Details

Daily high

$54.81

Daily low

$51.74

Price at open

$53.97

52 Week High

$58.90

52 Week Low

$12.56

Market cap

3.8B

Dividend yield

Volume

382,207

Avg. volume

677,252

P/E ratio

-45.87

Pulse Biosciences, Inc - Common Stock News